Request a Premium Quote Breaking News Coave Therapeutics Preparing for Retinitis Pigmentosa Gene Therapy Registration Trial Precigen to Begin Phase II Study of PRGN-2009, Keytruda in HPV-Positive Cervical Cancer RayzeBio Advances RYZ101 to Phase III Study in SSTR-Positive Neuroendocrine Tumors Yuhan Licenses HER2 Inhibitor From J INTS Bio in $325M Deal Anew Medical Expecting to Access $54M Following SPAC Merger FDA Reviewing Iovance's BLA for Melanoma TIL Therapy; Decision Expected in November
